Company Long-Term Loans and Borrowings: 89bio Corp (ETNB)

Public company logo of 89bio Corp (ETNB)

89bio, Inc. ensures the preservation of biomaterials through diversified logistics channels, although the business is heavily dependent on the outcome of its lead drug trials. Changes in the company's long-term debt reflect liability dynamics, where 0.04 shows the current volume of this metric. Simultaneously, 89bio, Inc. is implementing energy-saving technologies and reducing toxic waste in laboratories in accordance with ESG environmental standards.

ETNB 89bio, Inc. Company Long-Term Debts (07/04/2022 - 11/15/2025)

Summary analytical data breakdowns for 89bio Corp (ETNB)

- market price and analyst price targets:
Stock Price 89bio.com|ETNB - Price Target Chart
- company stock exchange capitalization indicators:
Market Value 89bio|ETNB - Total Company Value
- book capitalization information:
Accounting Value per Share 89bio|ETNB - Book Capitalization|Market Capitalization to Book Value Ratio 89bio.com|ETNB - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio 89bio, Inc.|ETNB - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio 89bio Pharma|ETNB - Company Aggregate Debts|Debts to Book Value 89bio|ETNB - Company Long-Term Liabilities|Amount of Current Liabilities 89bio
Summary company analytics:89bio, Inc.
Brand item of 89bio, Inc.

Long-term debt reflects the aggregate of obligations with maturities exceeding twelve months, allowing investors to assess the stability of the capital structure and default risks. By analyzing the magnitude of the company's long-term debt on GURU.Markets, one can understand how effectively 89bio, Inc. (ETNB) finances the development of metabolic liver disease therapies to ensure future stable patent revenues and long-term business capitalization.

Competitor analysis for 89bio, Inc.

Company Long-Term Debts ascendispharma.com ASND|MDGL - Company Long-Term Debt|Company Long-Term Loans and Borrowings CORT (Corcept Therapeutics Inc.)|Rhythm Pharmaceuticals Inc (RYTM) - Company Long-Term Debt|Company Long-Term Liabilities Akero Corp|MTSR (Metsera Inc) - Company Long-Term Debts|Company Long-Term Debts moonlaketx.com|Company Long-Term Liabilities CRNX (Crinetics)|NAMS (NewAmsterdam Pharma Company) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Soleno SLNO|FOLD - Company Long-Term Liabilities|Agios Pharmaceuticals - Company Long-Term Debts|Long-Term Debt structuretx.com|MDXG (MiMedx) - Company Long-Term Liabilities|RZLT: Amount of Long-Term Liabilities|LXRX (Lexicon Pharma) - Company Long-Term Debts|Company Long-Term Debts MBX Corp|Company Long-Term Debts ALT|Company Long-Term Debt AARD (aardvarktherapeutics.com)|Company Long-Term Debt Sagimet Biosciences Inc. SGMT|BioAge Labs (BIOA) - Long-Term Debt|BMEA - Company Long-Term Debt|QNCX: Company Long-Term Debt|GUTS: Company Long-Term Debts|VTVT - Long-Term Debt Volume|Company Long-Term Debt Agape ATP Corp|Pluri Inc (PLUR) - Long-Term Debt Volume|Company Long-Term Debt Synlogic, Inc. (SYBX)|Company Long-Term Liabilities Lipocine Corporation LPCN|Company Long-Term Loans and Borrowings Matinas BioPharma Holdings|Long-Term Debt Volume Spruce Biosciences Inc. (SPRB)|Galecto - Company Long-Term Debts|CTCX: Company Long-Term Debt|LUMO: Company Long-Term Debts|ONVO - Long-Term Debt Volume|Company Long-Term Debt Radius Recycling, Inc.